ArticleLeukemia & lymphoma2016

Incidence and management of myelosuppression in patients with chronic- and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate.

Luke Akard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.